Dr Christopher E Paoloni, MD | |
13700 St Francis Blvd Ste 603, Midlothian, VA 23114-3223 | |
(804) 362-0808 | |
(804) 414-7552 |
Full Name | Dr Christopher E Paoloni |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 21 Years |
Location | 13700 St Francis Blvd Ste 603, Midlothian, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215080007 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 242483 (New York) | Secondary |
207V00000X | Obstetrics & Gynecology | 0101241161 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bon Secours St Francis Medical Center | Midlothian, VA | Hospital |
Entity Name | Virginia Physicians For Women, Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639137979 PECOS PAC ID: 8628057924 Enrollment ID: O20040720000074 |
News Archive
The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.
When breast cancer becomes advanced and spreads to other organs, patient survival is drastically reduced, prompting the need to explore the genes that may cause tumor cells to metastasize.
When it comes to skin infections, a healthy and robust immune response may depend greatly upon what lies beneath. In a new paper published in the January 2, 2015 issue of Science, researchers at the University of California, San Diego School of Medicine report the surprising discovery that fat cells below the skin help protect us from bacteria.
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
› Verified 5 days ago
Entity Name | Obhg Virginia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.
When breast cancer becomes advanced and spreads to other organs, patient survival is drastically reduced, prompting the need to explore the genes that may cause tumor cells to metastasize.
When it comes to skin infections, a healthy and robust immune response may depend greatly upon what lies beneath. In a new paper published in the January 2, 2015 issue of Science, researchers at the University of California, San Diego School of Medicine report the surprising discovery that fat cells below the skin help protect us from bacteria.
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
› Verified 5 days ago
Entity Name | River City Ob/gyn Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417447657 PECOS PAC ID: 4082967161 Enrollment ID: O20181019002748 |
News Archive
The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.
When breast cancer becomes advanced and spreads to other organs, patient survival is drastically reduced, prompting the need to explore the genes that may cause tumor cells to metastasize.
When it comes to skin infections, a healthy and robust immune response may depend greatly upon what lies beneath. In a new paper published in the January 2, 2015 issue of Science, researchers at the University of California, San Diego School of Medicine report the surprising discovery that fat cells below the skin help protect us from bacteria.
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Christopher E Paoloni, MD Po Box 8310, Roanoke, VA 24014-0310 Ph: (540) 345-3556 | Dr Christopher E Paoloni, MD 13700 St Francis Blvd Ste 603, Midlothian, VA 23114-3223 Ph: (804) 362-0808 |
News Archive
The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants – babies less than 1500 grams.
When breast cancer becomes advanced and spreads to other organs, patient survival is drastically reduced, prompting the need to explore the genes that may cause tumor cells to metastasize.
When it comes to skin infections, a healthy and robust immune response may depend greatly upon what lies beneath. In a new paper published in the January 2, 2015 issue of Science, researchers at the University of California, San Diego School of Medicine report the surprising discovery that fat cells below the skin help protect us from bacteria.
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
› Verified 5 days ago
Dr. Tracy Hicks, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 305, Midlothian, VA 23114 Phone: 804-320-2483 Fax: 804-419-1860 | |
Amy Hazzard Moore, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 13801 St Francis Blvd Ste 100, Midlothian, VA 23114 Phone: 804-288-4084 | |
Laura Grace Deal, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 13710 St Francis Blvd Ste 305, Midlothian, VA 23114 Phone: 804-320-2483 | |
Kathryn Dianne Lucas, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 13801 St Francis Blvd, Midlothian, VA 23114 Phone: 804-897-2100 | |
Sara I Sarraf, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13801 St Francis Blvd Ste 100, Midlothian, VA 23114 Phone: 804-288-4084 Fax: 804-545-9548 | |
Dr. Flora Williams, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 305, Midlothian, VA 23114 Phone: 804-320-2483 Fax: 804-419-1860 |